medtronic dividend - Search News

News

Medtronic to spin off diabetes business

Medtronic Beats Q4 Forecasts, Hikes Dividend, Plans Diabetes Spinoff

The separation is also expected to allow Medtronic to retire outstanding shares without impacting cash, leading to further EPS accretion and a reduced dividend liability. Investors can gain exposure to the stock via Madison ETFs Trust Madison Covered Call ETF CVRD and Absolute Select Value ETF ABEQ.

MarketWatch · 1d

Medtronic Boosts Dividend, Plans to Separate Diabetes Business and Targets Revenue Growth for Year

Medtronic bumped up its dividend payout and unveiled plans to spin off its diabetes business as the medical-device company targeted revenue growth for the new fiscal year of roughly 5%.

Newswire · 1d

Medtronic announces intent to separate Diabetes business

CNW/ -- (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a

18hon MSN

This Undervalued Dividend Aristocrat Just Raised its Dividend

Medtronic plc (NYSE:MDT) declared a 1.4% hike in its dividend, which took its quarterly dividend to $0.71 per share.

Medtronic Raises Dividend by 1.4%, Extending Royal Payout Run

Medtronic's board has bumped up its quarterly dividend by a penny, to 71 cents, marking the 48th straight year that the medical-technology company has boosted its payout. The new dividend, equal to $2 ...

Medtronic PLC (MDT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves

Medtronic PLC (MDT) reports robust organic growth and strategic initiatives, including a Diabetes business spin-off, to ...

3don MSN

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investing.com India1d

Medtronic tops Q4 forecasts, misses on outlook; plans to spin off diabetes unit

Medtronic (NYSE:MDT) reported fourth-quarter results that surpassed analyst estimates, while its full-year guidance fell ...

Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025.

Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings

Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year. Read my MDT earnings preview.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results